Table 2.
Text Message Assessments | Active (%) | Placebo (%) | Active* (%) | Placebo* (%) | Efficacy Results | 95% CI |
---|---|---|---|---|---|---|
Overall Response Rate (# Responded to/# Sent) | 179/213 (84%) | 160/215 (74%) | 179/195 (92%) | 160/173 (92%) | n/a | |
Daily Self-Reported Use | 32/35 (91%) | 26/35 (74%) | 32/32 (100%) | 26/28 (93%) | 1 day use (total) in active phase & 2 days use (total) in placebo phase | n/a |
Usefulness Ratings | 119/143 (83%) | 110/145 (76%) | 119/131 (91%) | 110/117 (94%) | 6.6 OR** | [2.2, 19.4] |
Daily Peak Craving*** | 28/35 (80%) | 24/35 (69%) | 28/32 (88%) | 24/28 (86%) | Mean 3.3 in placebo phase; 40% higher in the active phase | [2.8, 3.8]; [9%, 80%] |
Excludes from the denominators post Day 5 messages for participant who discontinued responding prematurely due to his arrest.
Odds of messages being rated as “very” or “extremely” useful (versus “not at all,” “slightly” or “moderately”).
On a scale of 0–10, where 0 is “no craving” and 10 is “most ever experienced”